Joinn Laboratories(China)Co.,Ltd.

SSE:603127.SS

19.8 (CNY) • At close June 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Revenue 287.337687.057484.29524.547322.439787.472575.002642.691369.386991.578499.512505.906270.975659.876322.248333.564200.993444.392234.158242.641154.714290.924147.591126.44574.419165.038108.63683.49151.633131.50874.75676.0818.935124.22248.761
Cost of Revenue 205.133476.309376.828373.266218.157479.729328.946385.08178.43539.678245.51265.556130.915346.647167.662165.9297.328205.945119.123119.34878.677134.03370.1763.38835.22678.20248.07242.42223.35458.04329.68434.169.86860.16825.795
Gross Profit 82.204210.749107.461151.281104.282307.743246.057257.612190.956451.9254.002240.35140.06313.229154.586167.643103.664238.447115.035123.29476.037156.89177.42163.05739.19386.83660.56441.06928.27873.46545.07241.929.06764.05322.966
Gross Profit Ratio 0.2860.3070.2220.2880.3230.3910.4280.4010.5170.4560.5090.4750.5170.4750.480.5030.5160.5370.4910.5080.4910.5390.5250.4990.5270.5260.5570.4920.5480.5590.6030.5510.4790.5160.471
Reseach & Development Expenses 23.02821.83323.24624.87222.96717.09620.70629.32227.61227.93124.57213.19312.28912.73613.15911.9829.8791.77320.83116.29411.76112.88310.7848.5787.3835.5017.614.8455.7346.5174.85714.203013.8290
General & Administrative Expenses 71.784-133.08173.645-8.87171.962-140.226186.179-31.48674.544-154.787187.998-18.70363.923-99.004138.029-9.60267.11-56.31448.797-14.19646.014-21.22624.11-1.48219.507-10.87318.436-2.99519.814-27.74818.158-5.55617.885-20.56516.842
Selling & Marketing Expenses 6.079-11.25614.1196.3135.856.2826.4676.5055.3615.6184.2054.2383.9474.3624.3574.0563.1983.1223.2953.3763.1154.4173.0522.8432.1622.3961.4081.6691.1531.8682.0850.9570.8431.1720.955
SG&A 77.863-146.204187.765-2.55979.6858.071192.645-24.98179.905-149.169192.203-14.46667.87-94.642142.386-5.54670.307-53.19252.092-10.8249.129-16.80927.1621.3621.668-8.47719.844-1.32620.967-25.87920.244-4.59818.728-19.39317.798
Other Expenses -68.07749.387-209.533-255.764-26.264-25.814198.265-198.324-9.682202.366-111.456107.11-3.3125.68-90.75193.276-3.76754.706-0.1530.07-0.436-0.3140.073-0.011-0.0011.324-0.0090.0320.499-1.3560.0780.0280.492.2081.927
Operating Expenses 32.822223.3681.478115.668128.912100.98101.578111.6597.83481.128105.319105.83876.85967.676.15779.11564.30866.39465.9861.20757.43339.23336.45731.15826.94631.25822.7327.33919.76321.16218.43719.19518.37119.76518.988
Operating Income 49.383-94.37107.494115.854-24.63206.763275.246-97.531214.37507.86370.108280.834101.809361.344107.67866.063107.803227.50349.30761.84922.458114.55543.88532.19915.50457.70940.97716.94210.38354.67726.41621.933-8.85144.9264.003
Operating Income Ratio 0.172-0.1370.2220.221-0.0760.2630.479-0.1520.580.5120.140.5550.3760.5480.3340.1980.5360.5120.2110.2550.1450.3940.2970.2550.2080.350.3770.2030.2010.4160.3530.288-0.4670.3620.082
Total Other Income Expenses Net 0.001267.743-0.035-0.075-267.942-0.046-0.1960.137-0.041-0.0651.22214.557-0.0690.357-0.0082.533-3.76726.238-0.1530.07-0.436-9.1540.073-0.011-0.0011.324-0.0090.0320.499-1.3530.0770.0270.492.1591.923
Income Before Tax 49.384173.373107.459115.779-292.571115.481275.05-97.393214.329507.798297.056295.391139.757361.702107.67168.595104.036227.47749.15461.91922.022114.24143.95832.18815.50359.03240.96916.97410.88153.32426.49221.961-8.36147.0855.926
Income Before Tax Ratio 0.1720.2520.2220.221-0.9070.1470.478-0.1520.580.5120.5950.5840.5160.5480.3340.2060.5180.5120.210.2550.1420.3930.2980.2550.2080.3580.3770.2030.2110.4050.3540.289-0.4420.3790.122
Income Tax Expense 8.26429.9329.46514.654-19.76649.6138.3610.80926.61965.5736.46849.88614.87752.29513.7548.60210.93631.0577.215.4633.21512.0037.8764.1923.6078.0426.2113.3052.11111.5374.0172.859-1.4447.3590.771
Net Income 41.119144.38299.436102.48-272.22269.394236.971-97.133187.76442.224260.914245.772125.347309.45394.27160.37893.357196.7342.61956.51819.128101.8936.78828.09712.0451.11634.78313.6698.77141.78722.47619.101-6.91739.7265.156
Net Income Ratio 0.1430.210.2050.195-0.8440.0880.412-0.1510.5080.4460.5220.4860.4630.4690.2930.1810.4640.4430.1820.2330.1240.350.2490.2220.1620.310.320.1640.170.3180.3010.251-0.3650.320.106
EPS 0.050.190.130.14-0.360.0930.32-0.130.250.590.690.650.240.810.280.180.140.590.0690.180.0330.330.0590.120.0260.220.0560.0450.0150.170.0370.079-0.0150.180.012
EPS Diluted 0.050.190.130.14-0.360.0930.32-0.130.250.830.690.650.240.810.280.180.140.590.0690.180.0330.330.0590.120.0260.220.0560.0450.0150.170.0370.079-0.0150.180.012
EBITDA 49.905268.077109.287115.125-255.682243.512277.39-59.851251.759542.549299.572294.681173.556391.747136.29292.534128.02248.45649.32962.08931.358120.82856.55741.90625.22166.90837.83419.348.51553.38227.90323.363-9.5551.8813.979
EBITDA Ratio 0.1740.390.2260.219-0.7930.3090.482-0.0930.6820.5470.60.5820.640.5940.4230.2770.6370.5590.2110.2560.2030.4150.3830.3310.3390.4050.3480.2320.1650.4060.3730.307-0.5040.4180.082